Kinase Suppressor of Ras (KSR) is a molecular scaffold that interacts with the core kinase components of the ERK cascade, Raf, MEK, and ERK and provides spatial and temporal regulation of Ras-dependent ERK cascade signaling. In this report, we identify the heterotetrameric protein kinase, casein kinase 2 (CK2), as a new KSR1-binding partner. Moreover, we find that the KSR1/CK2 interaction is required for KSR1 to maximally facilitate ERK cascade signaling and contributes to the regulation of Raf kinase activity. Binding of the CK2 holoenzyme is constitutive and requires the basic surface region of the KSR1 atypical C1 domain. Loss of CK2 binding does not alter the membrane translocation of KSR1 or its interaction with ERK cascade components; however, disruption of the KSR1/CK2 interaction or inhibition of CK2 activity significantly reduces the growth-factor-induced phosphorylation of C-Raf and B-Raf on the activating serine site in the negative-charge regulatory region (N-region). This decrease in Raf N-region phosphorylation further correlates with impaired Raf, MEK, and ERK activation. These findings identify CK2 as a novel component of the KSR1 scaffolding complex that facilitates ERK cascade signaling by functioning as a Raf family N-Region kinase.
associating with KSR1 in these complexes. Many of the known KSR1-interacting molecules were detected as were peptides derived from the a, a 0 , and b subunits of CK2 (see Figure S1 in the Supplemental Data available with this article online). CK2 is a heterotetrameric serine/ threonine kinase composed of two regulatory (b) and two catalytic (a and/or a 0 ) subunits [3, 4] . Coimmunoprecipitation assays confirmed the KSR1/CK2 interaction and demonstrated the association of endogenous KSR1 and CK2 in mouse brain tissues ( Figures 1A and  1B) . Moreover, binding of the CK2 subunits was found to be constitutive and did not change with growth-factor treatment.
The CK2 Holoezyme Binds to the Basic Surface Region of the KSR1 Atypical C1 Domain By using a series of KSR1 deletion mutants to determine the region of KSR1 required for CK2 binding, we localized the CK2 interaction site to KSR1 residues 320-424, a region encompassing the KSR1 C1 domain ( Figure 1C ). CK2 did not interact with a chimeric KSR1 protein, in which the C1 domain of KSR1 was replaced with the closely related C1 domain from C-Raf (C1R-KSR1) and was not detected in complexes containing the wildtype C-Raf protein, indicating that CK2 binds selectively to the KSR1 C1 domain ( Figure 1D ). Strikingly, we found that the basic surface region, which is unique to the KSR1 C1 domain [5] , was critical for CK2 binding. Mutation of lysine 360 and arginine 363 to either alanine residues (KR/AA) or to glutamine and glycine residues KR/ QG (as found in the C-Raf C1 domain) abolished CK2 binding but had no effect on the association of MEK and 14-3-3, proteins that bind to sites outside the C1 domain ( Figure 1E ). Moreover, by using bacterially-expressed, recombinant CK2 proteins, we found that the a, a 0 , and b subunits were all capable of associating with WT-KSR1 in in vitro-binding assays but showed little to no interaction with KR/AA-KSR1 ( Figure 1F ).
Loss of CK2 Binding Alters the ERK Scaffolding Activity of KSR1
The CK2 holoenzyme exhibits constitutive catalytic activity, and an apparent consequence of the KSR1/CK2 interaction is the constitutive phosphorylation of KSR1 on S518 ( [6] and Figure S2 ), a site contained within a consensus CK2 phosphorylation motif (S/T-x-x-E/D/pY/pS/ pT [7] ). To investigate the functional significance of the KSR1/CK2 interaction, we examined KSR1 mutants defective in either CK2 binding (KR/AA-KSR1) or CK2-mediated S518 phosphorylation (S518A-KSR1) for their ERK scaffolding activity and subcellular localization. Although these mutants showed no defect in MEK or ERK binding, KR/AA-KSR1 complexes isolated from PDGFtreated NIH 3T3 cells contained significantly reduced levels of activated phosphoMEK and phosphoERK in comparison to WT-and S518-KSR1 complexes (Figure 2A) . These results indicate a deficiency in the ERK scaffolding activity of KR/AA-KSR1, and this deficiency was also observed in the Xenopus oocyte meiotic maturation assay. In this system, coexpression of WT-KSR1 with Ras V12 or activated receptor tyrosine kinases increases the rate of MEK and ERK activation and thus results in faster oocyte maturation [8] . However, unlike WT-and S518A-KSR1, KR/AA-KSR1 did not accelerate oocyte maturation in response to Tpr-MET or EGF receptor activation, and oocytes expressing KR/AA-KSR1 displayed significantly lower levels of activated MEK and ERK than did those expressing WT-or S518A-KSR1 ( Figure 2B and Figure S3 ). Thus, in two different assay systems, loss of CK2 binding impaired KSR1's ability to facilitate MEK and ERK activation. In contrast, despite the constitutive phosphorylation of KSR1 on S518, mutation of this site had no apparent effect in these assays, and the biological significance of S518 phosphorylation is currently unknown.
The translocation of KSR1 to the plasma membrane after signal activation is critical for its scaffolding function, and this process requires the C1 domain [5, 9] . Significantly, we found that although the KR/AA mutation in the KSR1 C1 domain disrupts CK2 binding, it did not alter the membrane localization of KSR1 after mitogen stimulation ( Figure 2C ). Moreover, cell-fractionation experiments revealed that CK2 is a component of the membrane-localized WT-KSR1 complexes ( Figure 2C ).
CK2 Contributes to the ERK Scaffolding Activity of KSR1 by Functioning as a Raf N-Region Serine Kinase
The above results indicate that the KSR1/CK2 interaction is required for maximal KSR1 scaffolding activity. However, because loss of CK2 binding does not alter the ability of KSR1 to bind MEK and ERK or to translocate to the plasma membrane in an inducible manner, it appears that the scaffolding defect of the KR/AA-KSR1 mutant lies upstream of MEK and might thus impact Raf kinase activity. Mammalian cells contain three Raf kinases, A-Raf, B-Raf, and C-Raf, and activation of all three enzymes depends on the phosphorylation of residues in two regions of the catalytic domain: the activation segment and the negative-charge regulatory region (N-region) [10, 11] . Analysis of the Raf sequences indicated that the activating serine site in the N-region (E) Pyo-tagged KSR1 proteins were immunoprecipitated and examined by immunoblot analysis as indicated. Also shown are the ribbon and surface charge diagrams of the KSR1 C1 domain [5] depicting the K360 and R363 residues required for CK2 binding. (F) Affinity-immobilized recombinant CK2a, CK2a 0 , and CK2b were incubated with lysates containing WT-or KR/AA-KSR1 and examined for KSR1 association by immunoblot analysis. might be a target for CK2 phosphorylation ( Figure 3A ). For C-Raf and A-Raf, this serine (C-Raf S338, A-Raf S299) is followed at the +2/+3 positions by tyrosine residues known to be phosphorylated under certain signaling conditions [10] [11] [12] and, as a result, might be a potential CK2 target after the phosphorylation of these residues. In contrast, B-Raf contains negatively charged aspartic-acid residues at the +2/+3 positions, suggesting that the B-Raf N-region serine (S446) might be a constitutive CK2 target.
To determine whether the Raf kinases are CK2 substrates, we performed in vitro kinase assays by using recombinant CK2a and affinity-purified, kinase-dead (KD) B-Raf and C-Raf proteins (to ensure that any in vitro phosphorylation detected could be attributed to CK2 activity and not Raf autophosphorylation). A-Raf was not included in these experiments, given its sequence similarity to C-Raf. As shown in Figure 3B , CK2 efficiently phosphorylated KD/B-Raf but could only phosphorylate KD/C-Raf that had been coexpressed with v-Src (to induce Y341 phosphorylation) or contained an aspartic-acid residue at the 341 site. Analysis of the labeled proteins indicated that C-Raf was phosphorylated on one major site, S338, whereas B-Raf was phosphorylated on two sites, S446 and S430, which also lies in a CK2 phosphorylation motif ( Figure S4) . Thus, the activating serine site in the Raf N-region is a target of CK2 in vitro but only when a negatively-charged residue is present at the +3 position (either an acidic amino acid or a phosphorylated residue).
By using NIH 3T3 cells that stably express either WTor KR/AA-KSR1, we next investigated the contribution of KSR1-bound CK2 to Raf N-region phosphorylation in vivo. As shown in Figure 3C , the growth-factor-induced phosphorylation of C-Raf at the N-region S338 site was dramatically reduced in cells expressing KR/AA-KSR1, whereas phosphorylation of the nearby Y341 site was unaffected. Consistent with previous reports [10] , basal N-region phosphorylation of B-Raf S446 was elevated in comparison to C-Raf S338. Nonetheless, PDGF treatment increased B-Raf phosphoS446 levels approximately 3-fold in WT-KSR1-expressing cells but had little effect on cells expressing KR/AA-KSR1 ( Figure 3C ). The reduction in N-region serine phosphorylation also correlated with a decrease in the growth-factor-induced activation of C-Raf and B-Raf in KR/AA-expressing cells ( Figure 3D ). In addition, reduced C-Raf S338 and B-Raf S446 phosphorylation was also observed when KR/AA-KSR1 function was examined during EGF-induced Xenopus oocyte maturation ( Figure 3E ). Strikingly, B-Raf phosphoS446 levels were almost undetectable in arrested stage VI oocytes, and our preliminary analysis suggests that the basal phosphorylation of B-Raf S446 can vary dramatically depending on cell type, signaling state of the cell, and the endogenous levels of KSR1, CK2, and B-Raf (data not shown).
To further investigate the involvement of CK2 in Raf Nregion phosphorylation, we assessed the effects of reducing CK2 activity. Although we found that expression of the CK2 subunits could be knocked down by using RNAi, efficient depletion of CK2 resulted in a dramatic loss of cell viability (data not shown), likely reflecting the fact that CK2 is an essential protein kinase with many cellular substrates [7] . However, when CK2 activity was transiently inhibited with 2-dimethylamino-4,5,6,7-tetrabromo-1 H-benzimidazole (TBB), a pronounced effect on Raf N-region phosphorylation was observed. Pretreatment of WT-KSR1-expressing NIH 3T3 cells with TBB significantly reduced the levels of B-Raf S446 and C-Raf S338 phosphorylation induced by PDGF treatment, whereas C-Raf Y341 phosphorylation was unaffected ( Figure 3C) .
The above findings identify CK2 as a Raf family N-region kinase. Although Pak kinases have been shown to phosphorylate the C-Raf N-region S338 site [13] [14] [15] , it appears that the Paks are not major contributors to the growth-factor-induced S338 phosphorylation observed in WT-KSR1-expressing cells. By using the Pak1 autoinhibitory domain (PID) to suppress Pak activation [16] , we found that PID expression had no effect on C-Raf phosphoS338 levels in EGF-treated cells expressing WT-KSR1 and that it caused no further inhibition of S338 phosphorylation in cells expressing the KR/AA-KSR1 mutant ( Figure S5 ). Interestingly, we found that EGF treatment had only a modest effect on Pak activity ( Figure S5 ), and our results identifying CK2 as a Raf Nregion kinase are consistent with the previous finding that cells contain another kinase whose ability to phosphorylate the S338 site is dependent on Y341 phosphorylation [10, 17] .
KSR1 has been shown to associate with C-Raf in a growth-factor-inducible manner [18, 19] and, as a result, would colocalize CK2 with its potential target. Likewise, we found that B-Raf strongly interacts with KSR1 in growth-factor-treated KSR1-expressing NIH 3T3 cells ( Figure 4A ). Endogenous complex formation between KSR1 and B-Raf could also be detected in extracts of mouse brain tissue ( Figure 4B ). Strikingly, when B-Raf protein from WT and KSR1 2/2 brains was compared [20] , phosphorylation of S446 was reduced in KSR1 2/2 tissues ( Figure 4B ), providing evidence that KSR1 impacts B-Raf N-region phosphorylation in vivo. Notably, B-Raf isolated from the KSR1 2/2 brains was complexed with the other mammalian KSR scaffold, KSR2 (Figure 4B) , and given that KSR2 also interacts with CK2 (data not shown), it is possible that KSR2-bound CK2 may contribute to B-Raf S446 phosphorylation in the KSR1 2/2 animals. Taken together, these findings identify CK2 as a biologically relevant Raf N-region kinase and reveal a role for KSR1 in facilitating Raf kinase activation.
Conclusions
The results presented here identify CK2 as a novel component of the KSR1 scaffolding complex. Moreover, we find that when KSR1 translocates to the cell surface upon signal activation, not only does it colocalize MEK and ERK with the Raf family kinases but it also delivers the active CK2 holoenzyme, a kinase that contributes to Raf activation ( Figure 4C ). CK2 directly phosphorylates the activating serine site in the N-region of B-Raf (S446) and C-Raf (S338); however, in the case of CRaf, the N-region S338 site is also a target for other identified kinases, including members of the Pak and PKC families [13] [14] [15] 21] . Given that N-region phosphorylation is required for Raf activation, it is tempting to speculate that the N-region of C-Raf has evolved such that it can receive inputs from multiple upstream activators and thus allow C-Raf to integrate diverse signaling stimuli into appropriate ERK cascade activation. Strikingly, B-Raf and C-Raf are differentially regulated by CK2. Phosphorylation of the C-Raf N-region S338 site requires prior phosphorylation of Y341, most likely mediated by Src family kinases. In contrast, because of the acidic residues present in the B-Raf N-region, B-Raf is a constitutive CK2 target. The B-Raf N-region serine has been found to be more highly phosphorylated than the corresponding C-Raf site in many cell types, suggesting that CK2 might be particularly relevant for cell signaling and oncogenic transformation involving BRaf. Significantly, the finding that the KSR1 scaffolding complex contains a Raf activating kinase may help resolve the controversy over whether KSR1 has intrinsic kinase activity and may provide an explanation for the KSR1-associated Raf kinase activities that have been detected in previous studies and that have been attributed to KSR1 itself [22] [23] [24] . Based on the results presented here together with the findings that all mammalian KSR proteins lack a critical lysine residue normally required for the phosphotransfer reaction, we would propose that KSR1 contributes to Raf activation, not by directly phosphorylating the kinases but rather by localizing the Raf proteins with an upstream activating kinase, CK2. Interestingly, a recent report examining Ras-dependent ERK pathway activation in Drosophila S2 cells has also indicated a kinase-independent role for D-KSR in Raf activation [25] . In conclusion, these findings provide further insight into KSR1 function and demonstrate that the KSR1 scaffold acts at multiple points to ensure efficient activation and signal transmission through the ERK cascade's core kinase components-Raf, MEK, and ERK. 
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